Re: ESPR got crushed today
|
3
|
Resverlogix Corp.
|
May 03, 2018 04:20PM
|
Re: Esperion
|
3
|
Resverlogix Corp.
|
Mar 20, 2017 01:44PM
|
Re: Esperion
|
2
|
Resverlogix Corp.
|
Mar 20, 2017 02:39PM
|
Re: Esperion
|
|
Resverlogix Corp.
|
Mar 20, 2017 03:24PM
|
Re: Esperion
|
|
Resverlogix Corp.
|
Mar 20, 2017 04:12PM
|
Re: ESC Wrap Up for Sunday Sept 1....
|
5
|
Resverlogix Corp.
|
Sep 02, 2019 02:31AM
|
Re: ESC Wrap Up for Sunday Sept 1....
|
4
|
Resverlogix Corp.
|
Sep 03, 2019 06:51AM
|
Re: ESC Wrap Up for Sunday Sept 1....
|
2
|
Resverlogix Corp.
|
Sep 03, 2019 06:57AM
|
Re: ESC TV at ESC Congress 2019 - The Daily Wrap-Up - Tuesday 3 September
|
4
|
Resverlogix Corp.
|
Sep 04, 2019 11:09AM
|
Re: ESC TV at ESC Congress 2019 - The Daily Wrap-Up - Tuesday 3 September
|
4
|
Resverlogix Corp.
|
Sep 04, 2019 12:25PM
|
Re: ESC TV at ESC Congress 2019 - The Daily Wrap-Up - Monday 2 September
|
1
|
Resverlogix Corp.
|
Sep 03, 2019 05:50AM
|
Re: ESC Poster on BETonMACE Design and Baseline Data
|
2
|
Resverlogix Corp.
|
Sep 03, 2019 04:22PM
|
Re: ESC Poster on BETonMACE Design and Baseline Data
|
1
|
Resverlogix Corp.
|
Sep 03, 2019 06:21AM
|
Re: ERROR Re: Some wishful thinking....
|
2
|
Resverlogix Corp.
|
Jun 10, 2018 12:28PM
|
Re: ERROR Re: Some wishful thinking....
|
4
|
Resverlogix Corp.
|
Jun 11, 2018 01:01AM
|
Re: ERA-EDTA 2019 Symposium: Vascular calcification in kidney disease: Epigenetics as a novel approach?
|
3
|
Resverlogix Corp.
|
Apr 14, 2019 12:29PM
|
Re: Equity offering
|
4
|
Zenith Epigenetics
|
Jun 04, 2018 07:05PM
|
Re: Equity financing
|
5
|
Zenith Epigenetics
|
Jun 25, 2018 09:01PM
|
Re: Epizyme market cap $750 mil USd
|
4
|
Zenith Epigenetics
|
Jun 16, 2017 12:38PM
|
Re: Epigenetics in the News
|
2
|
Resverlogix Corp.
|
Sep 08, 2019 04:27AM
|